Trial evidence for thrombolysis in MI
The trial evidence for the use of thrombolysis in myocardial infarction is categorised according to the drug used:
- streptokinase
- tissue plasminogen activator
- APSAC
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.